Study Site 012 — Lexington, Kentucky

Study Site 012 is a clinical research site located in Lexington, Kentucky, United States 40536.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Study Site 012 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hypoxic-Ischemic Encephalopathy.

Sponsors: ReAlta Life Sciences, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site 012?

Study Site 012 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site 012 conducted?

Study Site 012 has 1 clinical trials on record, with 1 currently active. Their work covers Hypoxic-Ischemic Encephalopathy.

Is Study Site 012 accredited by Crixeo Health?

Study Site 012 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Study Site 012?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.